{"id":192290,"date":"2024-05-30T20:00:00","date_gmt":"2024-05-31T00:00:00","guid":{"rendered":"https:\/\/platohealth.ai\/?p=192290"},"modified":"2024-05-30T20:00:00","modified_gmt":"2024-05-31T00:00:00","slug":"virtual-mirror-therapy-for-relief-of-chronic-phantom-limb-pain","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/virtual-mirror-therapy-for-relief-of-chronic-phantom-limb-pain\/","title":{"rendered":"Virtual Mirror Therapy for Relief of Chronic Phantom Limb Pain","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"\n
\n

Studies<\/h3>\n\n\n\n\n\n\n\n\n\n <\/tr>\n<\/table><\/div>\n
\n

Detailed Descriptions<\/h3>\n

Study First Submitted Date<\/td>\n2021-12-06<\/td>\n<\/tr>\n
Study First Posted Date <\/td>\n2022-01-18<\/td>\n<\/tr>\n
Last Update Posted Date<\/td>\n2023-05-11<\/td>\n<\/tr>\n
Start Month Year<\/td>\nMay 2024<\/td>\n<\/tr>\n
Primary Completion Month Year<\/td>\nMay 2025<\/td>\n<\/tr>\n
Verification Month Year<\/td>\nMay 2023<\/td>\n<\/tr>\n
Verification Date<\/td>\n2023-05-31<\/td>\n<\/tr>\n
Last Update Posted Date<\/td>\n2023-05-11<\/td>\n<\/tr>\n
\n\n\n
Sequence:<\/td>\n20594147<\/td>\n<\/tr>\n
Description<\/td>\nTen unilateral upper extremity amputees suffering from chronic phantom limb pain > 1 yr will be recruited from a hospital based outpatient Physical Medicine and Rehabilitation Amputee Clinic. There will be no control group and all 10 subjects will be offered the use of a Virtual Reality headset therapy game (developed in Unreal Engine using Oculus Quest 2 SDK). Fiducial markers will be placed on the residual limb for tracking via front facing cameras on the Oculus Quest 2 and the sound limb movements will be duplicated (flipped for chirality) and mapped onto the residual limb to provide the appearance of their residual limb. The software will direct the subjects through a series of guided movements, stretches, and visualization exercises which last a total of 15 minutes. Afterwards the subjects will be given 5 minutes of unstructured time in the program to perform any of exercises or movements they desire in order to attempt to relieve their phantom limb pain. Subjects will aim for 1 session per week for a total of 6 weeks. Subjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) prior to and after each session. Prior to the first session as well as at 6 weeks and 12 weeks subjects will rate their phantom limb pain symptoms on the Pain Disability<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Facilities<\/h3>\n\n\n <\/tr>\n\n\n\n\n\n
Sequence:<\/td>\n198770553<\/td>\n<\/tr>\n
Name<\/td>\nThe University of Alabama at Birmingahm<\/td>\n<\/tr>\n
City<\/td>\nBirmingham<\/td>\n<\/tr>\n
State<\/td>\nAlabama<\/td>\n<\/tr>\n
Zip<\/td>\n35294<\/td>\n<\/tr>\n
Country<\/td>\nUnited States<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Conditions<\/h3>\n\n\n\n\n
Sequence:<\/td>\n51843559<\/td>\n<\/tr>\n
Name<\/td>\nPhantom Limb Pain<\/td>\n<\/tr>\n
Downcase Name<\/td>\nphantom limb pain<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Id Information<\/h3>\n\n\n\n\n <\/tr>\n <\/tr>\n <\/tr>\n<\/table><\/div>\n
\n

Countries<\/h3>\n

Sequence:<\/td>\n39896798<\/td>\n<\/tr>\n
Id Source<\/td>\norg_study_id<\/td>\n<\/tr>\n
Id Value<\/td>\nIRB-300007560<\/td>\n<\/tr>\n
\n\n\n\n
Sequence:<\/td>\n42295109<\/td>\n<\/tr>\n
Name<\/td>\nUnited States<\/td>\n<\/tr>\n
Removed<\/td>\nFalse<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Design Groups<\/h3>\n\n\n\n\n\n
Sequence:<\/td>\n55269246<\/td>\n<\/tr>\n
Group Type<\/td>\nExperimental<\/td>\n<\/tr>\n
Title<\/td>\nUnilateral upper extremity amputees<\/td>\n<\/tr>\n
Description<\/td>\nUnilateral upper extremity amputees suffering from chronic phantom limb pain > 1 yr will be recruited from a hospital based outpatient Physical Medicine and Rehabilitation Amputee Clinic at UAB.<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Interventions<\/h3>\n\n\n\n\n\n
Sequence:<\/td>\n52164292<\/td>\n<\/tr>\n
Intervention Type<\/td>\nOther<\/td>\n<\/tr>\n
Name<\/td>\nVirtual Mirror Therapy<\/td>\n<\/tr>\n
Description<\/td>\nSubjects will be offered the use of a Virtual Reality headset therapy game. Fiducial markers will be placed on the residual limb for tracking via front facing cameras on the Oculus Quest 2 and the sound limb movements will be duplicated (flipped for chirality) and mapped onto the residual limb to provide the appearance of their residual limb. The software will direct the subjects through a series of guided movements, stretches, and visualization exercises which last a total of 15 minutes. Afterwards the subjects will be given 5 minutes of unstructured time in the program to perform any of exercises or movements they desire in order to attempt to relieve their phantom limb pain.<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Keywords<\/h3>\n\n\n\n\n
Sequence:<\/td>\n79335316<\/td>\nSequence:<\/td>\n79335317<\/td>\n<\/tr>\n
Name<\/td>\nVirtual Mirror Therapy<\/td>\nName<\/td>\nChronic Phantom Limb Pain<\/td>\n<\/tr>\n
Downcase Name<\/td>\nvirtual mirror therapy<\/td>\nDowncase Name<\/td>\nchronic phantom limb pain<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Design Outcomes<\/h3>\n\n\n\n\n\n <\/tr>\n\n
Sequence:<\/td>\n176317068<\/td>\nSequence:<\/td>\n176317055<\/td>\nSequence:<\/td>\n176317056<\/td>\nSequence:<\/td>\n176317057<\/td>\nSequence:<\/td>\n176317058<\/td>\nSequence:<\/td>\n176317059<\/td>\nSequence:<\/td>\n176317060<\/td>\nSequence:<\/td>\n176317061<\/td>\nSequence:<\/td>\n176317062<\/td>\nSequence:<\/td>\n176317063<\/td>\nSequence:<\/td>\n176317064<\/td>\nSequence:<\/td>\n176317065<\/td>\nSequence:<\/td>\n176317066<\/td>\nSequence:<\/td>\n176317067<\/td>\nSequence:<\/td>\n176317069<\/td>\nSequence:<\/td>\n176317070<\/td>\nSequence:<\/td>\n176317071<\/td>\n<\/tr>\n
Outcome Type<\/td>\nsecondary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nprimary<\/td>\nOutcome Type<\/td>\nsecondary<\/td>\nOutcome Type<\/td>\nsecondary<\/td>\nOutcome Type<\/td>\nsecondary<\/td>\nOutcome Type<\/td>\nsecondary<\/td>\nOutcome Type<\/td>\nsecondary<\/td>\nOutcome Type<\/td>\nsecondary<\/td>\n<\/tr>\n
Measure<\/td>\nChange in Quality from Baseline Chronic Phantom Limb Pain at Session 4<\/td>\nMeasure<\/td>\nBaseline Numeric Rating Scale of Chronic Phantom Limb Pain<\/td>\nMeasure<\/td>\nChange from Baseline Numeric Rating Scale at Session1<\/td>\nMeasure<\/td>\nChange from Baseline Numeric Rating Scale at Session 2<\/td>\nMeasure<\/td>\nChange from Baseline Numeric Rating Scale at Session 3<\/td>\nMeasure<\/td>\nChange from Baseline Numeric Rating Scale at Session 4<\/td>\nMeasure<\/td>\nChange from Baseline Numeric Rating Scale at Session 5<\/td>\nMeasure<\/td>\nChange from Baseline Numeric Rating Scale at Session 6<\/td>\nMeasure<\/td>\nBaseline Pain Disability Questionnaire of Chronic Phantom Limb Pain<\/td>\nMeasure<\/td>\nChange from Baseline Pain Disability Questionnaire at Week 6<\/td>\nMeasure<\/td>\nChange from Baseline Pain Disability Questionnaire at Week 12<\/td>\nMeasure<\/td>\nChange in Quality from Baseline Chronic Phantom Limb Pain at Session1<\/td>\nMeasure<\/td>\nChange in Quality from Baseline Chronic Phantom Limb Pain at Session 2<\/td>\nMeasure<\/td>\nChange in Quality from Baseline Chronic Phantom Limb Pain at Session 3<\/td>\nMeasure<\/td>\nChange in Quality from Baseline Chronic Phantom Limb Pain at Session 5<\/td>\nMeasure<\/td>\nChange in Quality from Baseline Chronic Phantom Limb Pain at Session 6<\/td>\nMeasure<\/td>\nImpressions of change from Baseline Chronic Phantom Limb Pain at Session 6<\/td>\n<\/tr>\n
Time Frame<\/td>\nWeek 4 – Week 52<\/td>\nTime Frame<\/td>\nBaseline (Week 0)<\/td>\nTime Frame<\/td>\nWeek 1 – Week 52<\/td>\nTime Frame<\/td>\nWeek 2 – Week 52<\/td>\nTime Frame<\/td>\nWeek 3 – Week 52<\/td>\nTime Frame<\/td>\nWeek 4 – Week 52<\/td>\nTime Frame<\/td>\nWeek 5 – Week 52<\/td>\nTime Frame<\/td>\nWeek 6 – Week 52<\/td>\nTime Frame<\/td>\nBaseline (Week 0)<\/td>\nTime Frame<\/td>\n6 weeks after final session (Session 6)<\/td>\nTime Frame<\/td>\n12 weeks after final session (Session 6)<\/td>\nTime Frame<\/td>\nWeek 1 – Week 52<\/td>\nTime Frame<\/td>\nWeek 2 – Week 52<\/td>\nTime Frame<\/td>\nWeek 3 – Week 52<\/td>\nTime Frame<\/td>\nWeek 5 – Week 52<\/td>\nTime Frame<\/td>\nWeek 6 – Week 52<\/td>\nTime Frame<\/td>\nWeek 6 – Week 52<\/td>\n<\/tr>\n
Description<\/td>\nFree-text section where participants can further describe any changes regarding their pain (change in quality etc).<\/td>\nDescription<\/td>\nSubjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) at Baseline to use as comparison to each study session. If pain is intermittent or constant will be noted and if episodic\/intermittent a frequency for how often the pain occurs will be obtained as well.<\/td>\nDescription<\/td>\nSubjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) prior to and after each session. If pain is intermittent or constant will be noted and if episodic\/intermittent a frequency for how often the pain occurs will be obtained as well as if the pain is improved, unchanged, or worsened compared to baseline (prior to study).<\/td>\nDescription<\/td>\nSubjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) prior to and after each session. If pain is intermittent or constant will be noted and if episodic\/intermittent a frequency for how often the pain occurs will be obtained as well as if the pain is improved, unchanged, or worsened compared to baseline (prior to study).<\/td>\nDescription<\/td>\nSubjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) prior to and after each session. If pain is intermittent or constant will be noted and if episodic\/intermittent a frequency for how often the pain occurs will be obtained as well as if the pain is improved, unchanged, or worsened compared to baseline (prior to study).<\/td>\nDescription<\/td>\nSubjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) prior to and after each session. If pain is intermittent or constant will be noted and if episodic\/intermittent a frequency for how often the pain occurs will be obtained as well as if the pain is improved, unchanged, or worsened compared to baseline (prior to study).<\/td>\nDescription<\/td>\nSubjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) prior to and after each session. If pain is intermittent or constant will be noted and if episodic\/intermittent a frequency for how often the pain occurs will be obtained as well as if the pain is improved, unchanged, or worsened compared to baseline (prior to study).<\/td>\nDescription<\/td>\nSubjects will rate their phantom limb pain symptoms on the Numeric Rating Scale (NRS) prior to and after each session. If pain is intermittent or constant will be noted and if episodic\/intermittent a frequency for how often the pain occurs will be obtained as well as if the pain is improved, unchanged, or worsened compared to baseline (prior to study).<\/td>\nDescription<\/td>\nPrior to the first session as well as at 6 weeks and 12 weeks subjects will rate their phantom limb pain symptoms on the Pain Disability Questionnaire (PDQ).<\/td>\nDescription<\/td>\nPrior to the first session as well as at 6 weeks and 12 weeks subjects will rate their phantom limb pain symptoms on the Pain Disability Questionnaire (PDQ).<\/td>\nDescription<\/td>\nPrior to the first session as well as at 6 weeks and 12 weeks subjects will rate their phantom limb pain symptoms on the Pain Disability Questionnaire (PDQ).<\/td>\nDescription<\/td>\nFree-text section where participants can further describe any changes regarding their pain (change in quality etc).<\/td>\nDescription<\/td>\nFree-text section where participants can further describe any changes regarding their pain (change in quality etc).<\/td>\nDescription<\/td>\nFree-text section where participants can further describe any changes regarding their pain (change in quality etc).<\/td>\nDescription<\/td>\nFree-text section where participants can further describe any changes regarding their pain (change in quality etc).<\/td>\nDescription<\/td>\nFree-text section where participants can further describe any changes regarding their pain (change in quality etc).<\/td>\nDescription<\/td>\nAt the end of 6 sessions of Virtual Mirror Therapy subjects will be given the opportunity to submit opinions\/comments regarding their impressions of the sessions.<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Browse Conditions<\/h3>\n\n\n\n\n\n
Sequence:<\/td>\n192165309<\/td>\nSequence:<\/td>\n192165301<\/td>\nSequence:<\/td>\n192165302<\/td>\nSequence:<\/td>\n192165303<\/td>\nSequence:<\/td>\n192165304<\/td>\nSequence:<\/td>\n192165305<\/td>\nSequence:<\/td>\n192165306<\/td>\nSequence:<\/td>\n192165307<\/td>\nSequence:<\/td>\n192165308<\/td>\n<\/tr>\n
Mesh Term<\/td>\nPain<\/td>\nMesh Term<\/td>\nPhantom Limb<\/td>\nMesh Term<\/td>\nPerceptual Disorders<\/td>\nMesh Term<\/td>\nNeurobehavioral Manifestations<\/td>\nMesh Term<\/td>\nNeurologic Manifestations<\/td>\nMesh Term<\/td>\nNervous System Diseases<\/td>\nMesh Term<\/td>\nPain, Postoperative<\/td>\nMesh Term<\/td>\nPostoperative Complications<\/td>\nMesh Term<\/td>\nPathologic Processes<\/td>\n<\/tr>\n
Downcase Mesh Term<\/td>\npain<\/td>\nDowncase Mesh Term<\/td>\nphantom limb<\/td>\nDowncase Mesh Term<\/td>\nperceptual disorders<\/td>\nDowncase Mesh Term<\/td>\nneurobehavioral manifestations<\/td>\nDowncase Mesh Term<\/td>\nneurologic manifestations<\/td>\nDowncase Mesh Term<\/td>\nnervous system diseases<\/td>\nDowncase Mesh Term<\/td>\npain, postoperative<\/td>\nDowncase Mesh Term<\/td>\npostoperative complications<\/td>\nDowncase Mesh Term<\/td>\npathologic processes<\/td>\n<\/tr>\n
Mesh Type<\/td>\nmesh-ancestor<\/td>\nMesh Type<\/td>\nmesh-list<\/td>\nMesh Type<\/td>\nmesh-ancestor<\/td>\nMesh Type<\/td>\nmesh-ancestor<\/td>\nMesh Type<\/td>\nmesh-ancestor<\/td>\nMesh Type<\/td>\nmesh-ancestor<\/td>\nMesh Type<\/td>\nmesh-ancestor<\/td>\nMesh Type<\/td>\nmesh-ancestor<\/td>\nMesh Type<\/td>\nmesh-ancestor<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Sponsors<\/h3>\n\n\n\n\n\n
Sequence:<\/td>\n48015919<\/td>\n<\/tr>\n
Agency Class<\/td>\nOTHER<\/td>\n<\/tr>\n
Lead Or Collaborator<\/td>\nlead<\/td>\n<\/tr>\n
Name<\/td>\nUniversity of Alabama at Birmingham<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Overall Officials<\/h3>\n\n\n\n\n\n
Sequence:<\/td>\n29094276<\/td>\n<\/tr>\n
Role<\/td>\nPrincipal Investigator<\/td>\n<\/tr>\n
Name<\/td>\nConley Carr, MD<\/td>\n<\/tr>\n
Affiliation<\/td>\nThe University of Alabama at Birmingham<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Central Contacts<\/h3>\n\n\n\n\n\n\n <\/tr>\n\n
Sequence:<\/td>\n11941590<\/td>\n<\/tr>\n
Contact Type<\/td>\nprimary<\/td>\n<\/tr>\n
Name<\/td>\nConley Carr, MD<\/td>\n<\/tr>\n
Phone<\/td>\n(205) 934-2747<\/td>\n<\/tr>\n
Email<\/td>\ncjcarr@uabmc.edu<\/td>\n<\/tr>\n
Role<\/td>\nContact<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Design Group Interventions<\/h3>\n\n\n\n\n
Sequence:<\/td>\n67754939<\/td>\n<\/tr>\n
Design Group Id<\/td>\n55269246<\/td>\n<\/tr>\n
Intervention Id<\/td>\n52164292<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Eligibilities<\/h3>\n\n\n <\/tr>\n\n\n\n\n <\/tr>\n\n <\/tr>\n <\/tr>\n\n\n\n
Sequence:<\/td>\n30573692<\/td>\n<\/tr>\n
Gender<\/td>\nAll<\/td>\n<\/tr>\n
Minimum Age<\/td>\n18 Years<\/td>\n<\/tr>\n
Maximum Age<\/td>\n89 Years<\/td>\n<\/tr>\n
Healthy Volunteers<\/td>\nNo<\/td>\n<\/tr>\n
Criteria<\/td>\nInclusion Criteria: Presence of unilateral upper extremity amputation with continued intermittent or persistent phantom limb pain symptoms > 1 yr after amputation, pain must be >=4 of 10 on the VAS at least intermittently (i.e. can have no pain at times but they must at least have 4\/10 intensity of pain when pain does occur). Exclusion Criteria: Uncontrolled bipolar\/schizophrenia, active psychosis, uncontrolled seizure disorder, history of severe simulator sickness, active nausea\/vomiting, uncontrolled vertigo, bilateral blindness, any facial wounds around the cheeks nose or eyes that may interfere with headset, conjunctivitis, zoster ophthalmicus, immunodeficiency (uncontrolled HIV, immuno-suppressive medications, chemotherapy, etc), severe claustrophobia.<\/td>\n<\/tr>\n
Adult<\/td>\nTrue<\/td>\n<\/tr>\n
Child<\/td>\nFalse<\/td>\n<\/tr>\n
Older Adult<\/td>\nTrue<\/td>\n<\/tr>\n<\/table><\/div>\n
\n

Calculated Values<\/h3>\n\n\n\n <\/tr>\n <\/tr>\n\n <\/tr>\n <\/tr>\n\n <\/tr>\n\n\n\n\n\n\n\n\n <\/tr>\n<\/table><\/div>\n
\n

Designs<\/h3>\n

Sequence:<\/td>\n254292697<\/td>\n<\/tr>\n
Number Of Facilities<\/td>\n1<\/td>\n<\/tr>\n
Registered In Calendar Year<\/td>\n2021<\/td>\n<\/tr>\n
Were Results Reported<\/td>\nFalse<\/td>\n<\/tr>\n
Has Us Facility<\/td>\nTrue<\/td>\n<\/tr>\n
Has Single Facility<\/td>\nTrue<\/td>\n<\/tr>\n
Minimum Age Num<\/td>\n18<\/td>\n<\/tr>\n
Maximum Age Num<\/td>\n89<\/td>\n<\/tr>\n
Minimum Age Unit<\/td>\nYears<\/td>\n<\/tr>\n
Maximum Age Unit<\/td>\nYears<\/td>\n<\/tr>\n
Number Of Primary Outcomes To Measure<\/td>\n10<\/td>\n<\/tr>\n
Number Of Secondary Outcomes To Measure<\/td>\n7<\/td>\n<\/tr>\n
\n\n\n\n\n\n\n\n <\/tr>\n <\/tr>\n <\/tr>\n <\/tr>\n <\/tr>\n <\/tr>\n<\/table><\/div>\n
\n

Responsible Parties<\/h3>\n

Sequence:<\/td>\n30321903<\/td>\n<\/tr>\n
Allocation<\/td>\nN\/A<\/td>\n<\/tr>\n
Intervention Model<\/td>\nSingle Group Assignment<\/td>\n<\/tr>\n
Observational Model<\/td>\n<\/td>\n<\/tr>\n
Primary Purpose<\/td>\nTreatment<\/td>\n<\/tr>\n
Time Perspective<\/td>\n<\/td>\n<\/tr>\n
Masking<\/td>\nNone (Open Label)<\/td>\n<\/tr>\n
\n\n\n\n\n <\/tr>\n\n <\/tr>\n<\/table><\/div>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"

Studies Study First Submitted Date 2021-12-06 Study First Posted Date 2022-01-18 Last Update Posted Date 2023-05-11 Start Month Year May 2024 Primary Completion Month Year May 2025 Verification Month Year May 2023 Verification Date 2023-05-31 Last Update Posted Date 2023-05-11 Detailed Descriptions Sequence: 20594147 Description Ten unilateral upper extremity amputees suffering from chronic phantom limb […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":192291,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/192290"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=192290"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/192290\/revisions"}],"predecessor-version":[{"id":602013,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/192290\/revisions\/602013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/192291"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=192290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=192290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=192290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

Sequence:<\/td>\n28700622<\/td>\n<\/tr>\n
Responsible Party Type<\/td>\nPrincipal Investigator<\/td>\n<\/tr>\n
Name<\/td>\nConley Carr<\/td>\n<\/tr>\n
Title<\/td>\nAssistant Professor<\/td>\n<\/tr>\n
Affiliation<\/td>\nUniversity of Alabama at Birmingham<\/td>\n<\/tr>\n